T1	Participants 0 49	Amphotericin B in children with malignant disease
T2	Participants 372 403	children with malignant disease
T3	Participants 405 500	In an analysis of 82 children who received a full course of 6 days or more of AmB (117 courses)
T4	Participants 1084 1224	The pharmacokinetics of AmB were investigated in 20 children who received AmB in dextrose and 15 children who received AmB in lipid emulsion
